Partnering

We welcome partnering opportunities with academic and industry groups. INT has developed a broad IP portfolio focused on the use of LNPs for delivery of small molecules, and macromolecules such as nucleic acids and peptides.

We have a solid track record of successfully working with local and international partners to advance their preclinical assets. With deep understanding of drug development process from discovery to regulatory approval, we have formed long-lasting relationships with our partners.

Email us at bd@integratedntx.com to learn more about how our team and technologies can help you reach your drug development goals.